Front-line chemo-immunotherapy is not inferior to ibrutinib in CLL
van Gelder, M., Tournilhac, O., te Raa, D., Visser, H.P.J.
Published in Annals of oncology (01.11.2021)
Published in Annals of oncology (01.11.2021)
Get full text
Journal Article
Facial numbness as a symptom of a systemic disease
POEL, Y. H. M, SLIEKER, W. A. T, VISSER, H. P. J
Published in Netherlands journal of medicine (01.09.2011)
Get full text
Published in Netherlands journal of medicine (01.09.2011)
Journal Article
Haemolytic anaemia as a first sign of Wilson's disease
BALKEMA, S, HAMAKER, M. E, VISSER, H. P. J, HEINE, G. D. N, BEUERS, U
Published in Netherlands journal of medicine (01.09.2008)
Get full text
Published in Netherlands journal of medicine (01.09.2008)
Journal Article
Appropriate medication use in Dutch terminal care: study protocol of a multicentre stepped-wedge cluster randomized controlled trial (the AMUSE study)
van Hylckama Vlieg, M A M, Pot, I E, Visser, H P J, Jong, M A C, van der Vorst, M J D L, van Mastrigt, B J, Kiers, J N A, van den Homberg, P P P H, Thijs-Visser, M F, Oomen-de Hoop, E, van der Heide, A, van der Kuy, P H M, van der Rijt, C C D, Geijteman, E C T
Published in BMC palliative care (03.01.2024)
Published in BMC palliative care (03.01.2024)
Get full text
Journal Article
Treatment-specific risk of subsequent malignant neoplasms in five-year survivors of diffuse large B-cell lymphoma
Geurts, Y.M., Neppelenbroek, S.I.M., Aleman, B.M.P., Janus, C.P.M., Krol, A.D.G., van Spronsen, D.J., Plattel, W.J., Roesink, J.M., Verschueren, K.M.S., Zijlstra, J.M., Koene, H.R., Nijziel, M.R., Schimmel, E.C., de Jongh, E., Ong, F., te Boome, L.C.J., van Rijn, R.S., Böhmer, L.H., Ta, B.D.P., Visser, H.P.J., Posthuma, E.F.M., Bilgin, Y.M., Muller, K., van Kampen, D., So-Osman, C., Vermaat, J.S.P., de Weijer, R.J., Kersten, M.J., van Leeuwen, F.E., Schaapveld, M.
Published in ESMO open (01.02.2024)
Published in ESMO open (01.02.2024)
Get full text
Journal Article